Pergolizzi Joseph V, LeQuang Jo Ann, Taylor Robert, Raffa Robert B
a NEMA Research, Inc ., Naples , FL , USA.
b Department of Pharmacology & Toxicology , University of Arizona College of Pharmacy , Tucson , AZ , USA.
Postgrad Med. 2018 Jan;130(1):1-8. doi: 10.1080/00325481.2018.1407618. Epub 2017 Nov 30.
The opioid epidemic is associated with morbidity and mortality, and it has taken a vast toll on American society. While prescription opioid abuse is part of the opioid problem, it is by no means the entirety of it. Opioid abuse appears to have entered a technology-driven new world of clandestine labs all over the globe and many new synthetic analog, counterfeit, and adulterated drugs that arrive via the internet faster than the Drug Enforcement Administration (DEA) can catalog and outlaw them. To deal with opioid abuse, it must be recognized that it is more - far more - than a subset of chronic pain patients who become addicted. Indeed, to reduce the opioid epidemic to this population is to misunderstand it. The opioid epidemic involves illicit opioids, counterfeit opioids, new psychoactive substances, diverted opioids, and prescription opioids. The objective of this narrative review is to consider the roles of all substances that contribute to the opioid epidemic in America.
阿片类药物泛滥与发病率和死亡率相关,给美国社会造成了巨大损失。虽然处方阿片类药物滥用是阿片类药物问题的一部分,但绝非全部。阿片类药物滥用似乎已进入一个由技术驱动的全球秘密实验室的新世界,许多新型合成类似物、假冒和掺假药物通过互联网传播的速度比美国缉毒局(DEA)将其编入目录并宣布其为非法药物的速度还要快。为应对阿片类药物滥用问题,必须认识到,成瘾的不仅仅是——远远不止是——一部分慢性疼痛患者。事实上,将阿片类药物泛滥问题归结于这一人群是对该问题的误解。阿片类药物泛滥涉及非法阿片类药物、假冒阿片类药物、新型精神活性物质、被转移的阿片类药物和处方阿片类药物。本叙述性综述的目的是探讨在美国导致阿片类药物泛滥的所有物质所起的作用。